CIDP, a new partner of the Skinobs platform

15 February 2019

Incorporated in 2004 in Mauritius, the CIDP head office occupies today an area of 2000 m² with specially designed facilities for research and clinical activities as well as for all support functions (Data Management, Biostatistics, administrative areas…). We are located in the first regional Hub dedicated to biotechnologies: BioPark Mauritius.

The Mauritian population accounts for 1.2 Million inhabitants of multiethnic origins, with changes in lifestyle and rapid development, non-communicable and chronic diseases have been on the rise and account today for 80% of the diseases noted in the country. Some specific pathologies have a very high prevalence such as Diabetes Mellitus with over 120 000 diabetics on the island (23% of the population) and coronary heart disease (responsible for 30% of deaths).

Cancer is also on the rise with an average increase of 40% in newly reported cases since 2005. Skin diseases are very present such as psoriasis, atopic dermatitis, acne, vitiligo and other skin pigmentation disorders.

CIDP Mauritius has a staff of 60 members, all multilingual and with a very high level of qualification.

The Infrastructure

CIDP is headquartered in Mauritius with operating subsidiaries across four different countries worldwide (Brasil, India, Romania and Singapore), covering a total area of 4000m2, proposing 42 controlled examination rooms with the required equipment to accompany very specific clinical research needs, making CIDP a preponderant partner for the clinical development of your drug and medical device.  Within our facilities, we can undertake multi-centric trials from phase 1 (in dermatology) to phase 4 in several therapeutic areas.

In Mauritius, our activities incorporate an early stage discovery research facility, an in vitro Preclinical laboratory to better respond to the growing exigencies and demand of the pharmaceutical, cosmetic and agro industries.  We harbor within our different clusters the required state-of-the-art equipment to be a strong ally from investigational research, preclinical testing to clinical trials.

Over the years, CIDP Research & Innovation has double its extraction capacity and consolidated a natural product laboratory dedicated to the screening of extracts derived from local resources and capable of performing bioassay-guided fractionation and purification for discovery and characterisation of novel active molecules. Our Preclinical department shelter a BSL-2 cell culture laboratory (under accreditation for GLP) equipped with IVD flow cytometer, automated imaging system, transdermal diffusion cell and multi-mode plate readers and is capable of accommodating a wide variety of in vitro tests.   An ISO 17025-accredited modern analytical lab equipped with the latest technologies provides all the analytical solutions to meet both technical and quality exigencies. Furthermore, a BSL3 microbiological laboratory designed following the WHO recommendations confers the perfect setting for required microbiological testing and custom made researches.

With our high-technological set up, CIDP can be your premium partner and your one-stop solution for both product evaluation and product development.

Location

  • Mauritius
  • Romania
  • Singapour
  • India
  • Brazil

Our Team

CIDP comprises of highly qualified and experienced doctors, pharmacists, clinical research/trial assistants and managers, biostatisticians and data managers with extensive scientific expertise for your development projects.

Our dedicated research team holds PhD, MSc and BSc degrees in the field of Medical Sciences (Dermatology, Ophthalmology, Pediatric,…), Immunology, Microbiology, Biochemistry and Analytical Sciences. Our scientific know-how covers various aspects of drug discovery.

At CIDP, we strongly believe that our service standards rely on an extremely skilled workforce. Each of these highly trained and dedicated individuals contributes to the success of the company and that of our clients.

They work in close collaboration with a large network of healthcare professionals and scientists worldwide. These medical investigators are experienced specialists, recognized in their respective fields and trained in clinical trials; they form part of the CIDP family and work hand in hand with our staff to help you achieve your objectives.

Claire BLAZY JAUZAC – CEO

Following a successful career in clinical research at SANOFI (France), Claire BLAZY JAUZAC co-founded CIDP in 2004 with Jean-Louis ROULE. She pioneered the Quality Assurance department at CIDP, before being appointed as Head of Clinical Research.

Claire has played an integral role in the establishment of the legal framework for the conduct of Clinical Trials and GCP-based training programs in Mauritius.

Claire holds a PhD in Pharmacy (PharmD) and a Master’s degree in Pharmaceutical Control and Manufacturing from the Faculty of Pharmacy of Toulouse, France. Having trained at the ESSEC Business School, she has acquired world class leadership and management skills.

 

For more information, please visit www.cidp-cro.com.

CIDP-logo capture.carré.500

 

Retrieve all the testing expertise of CIDP on Skinobs.com,

and their Laboratory sheet : CIDP

Easily retrieve the methods and the CRO’s which support your product claims

Skinobs database and free connection: skinobs.com

Photo1.computer-Skinobs

Skinobs News Blog: skinobs.com/news

 


Save time and easily find the methods and the testing suppliers to substantiate your actives and cosmetics claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.